Immunic, Inc. (IMUX) Net income 2016–2025
Immunic, Inc. (IMUX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$97.2MFY2025 · since FY2016: -$41.0M → -$97.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.2M | +3.3% |
| FY2024 | -$100.5M | -7.4% |
| FY2023 | -$93.6M | +22.3% |
| FY2022 | -$120.4M | -29.5% |
| FY2021 | -$92.9M | -111.2% |
| FY2020 | -$44.0M | -26.0% |
| FY2019 | -$34.9M | -202.7% |
| FY2018 | -$11.5M | +77.8% |
| FY2017 | -$52.1M | -27.1% |
| FY2016 | -$41.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMUX financial trends
IMUX RevenueIMUX Net marginIMUX Gross profitIMUX Gross marginIMUX Operating incomeIMUX Operating marginIMUX Operating cash flowIMUX Free cash flowIMUX Capital expendituresIMUX Return on equityIMUX Stock buybacksIMUX Dividends paidIMUX Total assetsIMUX Total liabilitiesIMUX Shareholders’ equityIMUX overview →